Evidence map›Paper›PMID 28239658›Full record

ArticleJCI insight2017

Loss of immune homeostasis dictates SHIV rebound after stem-cell transplantation.

Christopher W Peterson, Clarisse Benne, Patricia Polacino, Jasbir Kaur, Cristina E McAllister, Abdelali Filali-Mouhim, Willi Obenza, Tiffany A Pecor, Meei-Li Huang, Audrey Baldessari and 8 more

Open access · goldAbstract read
In one paragraph

Article in JCI insight, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.5field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. CD20 CAR T cells safely and reversibly ablate B cell follicles in a non-human primate model of HIV persistence.Molecular therapy : the journal of the American Society of Gene Therapy · 2024
    Article
  5. Article
  6. Efficient manufacturing and engraftment ofMolecular therapy. Methods & clinical development · 2023
    Article
  7. Article
  8. Review
  9. EfficientFrontiers in immunology · 2023
    Article
  10. Article
  11. Genome editing in large animal models.Molecular therapy : the journal of the American Society of Gene Therapy · 2021
    Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Long-Term Persistence of Anti-HIV Broadly Neutralizing Antibody-Secreting Hematopoietic Cells in Humanized Mice.Molecular therapy : the journal of the American Society of Gene Therapy · 2019
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 3 institutions in 1 country.

Christopher W PetersonDivision of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Clarisse BenneDepartment of Pathology, Case Western Reserve University, Cleveland, Ohio, USA.
Patricia PolacinoWashington National Primate Research Center, Seattle, Washington, USA.
Jasbir KaurDivision of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Cristina E McAllisterDivision of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Abdelali Filali-MouhimDepartment of Pathology, Case Western Reserve University, Cleveland, Ohio, USA.
Willi ObenzaDivision of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Tiffany A PecorWashington National Primate Research Center, Seattle, Washington, USA.
Meei-Li HuangDivision of Vaccine and Infectious Diseases, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Audrey BaldessariWashington National Primate Research Center, Seattle, Washington, USA.
Robert D MurnaneWashington National Primate Research Center, Seattle, Washington, USA.
Ann E WoolfreyDivision of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Keith R JeromeDivision of Vaccine and Infectious Diseases, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Shiu-Lok HuWashington National Primate Research Center, Seattle, Washington, USA.
Nichole R KlattWashington National Primate Research Center, Seattle, Washington, USA.
Stephen DeRosaDivision of Vaccine and Infectious Diseases, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Rafick P SékalyDepartment of Pathology, Case Western Reserve University, Cleveland, Ohio, USA.
Hans-Peter KiemDivision of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Fred Hutch Cancer Center · USCase Western Reserve University · USUniversity of Washington · US

Funding

Washington National Primate Research CenterP51OD010425 · OD · UNIVERSITY OF WASHINGTON · PI Mari Ostendorf · 2012 to 2026
$201.8M
University of Washington/Fred Hutch Center for AIDS ResearchP30AI027757 · NIAID · UNIVERSITY OF WASHINGTON · PI EDWIN ROBERTO ORELLANA · 1988 to 2026
$104.9M
Cell and Gene Therapy for HIV CureUM1AI126623 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI JEROME, KEITH R, KIEM, HANS-PETER · 2016 to 2020
$24.2M
ZFN-Modified Stem Cells for HIV EradicationU19AI096111 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI ROSSI, JOHN JOSEPH · 2011 to 2015
$20.8M
Stem cell expansion and gene editing in a nonhuman primate model of HIV/AIDSU19HL129902 · NHLBI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI KIEM, HANS-PETER · 2015 to 2019
$12.8M
Engraftment and in vivo selection of HIV-protected stem cellsR01HL116217 · NHLBI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI KIEM, HANS-PETER · 2012 to 2017
$3.8M
NHLBI NIH HHS R01 HL116217NHLBI NIH HHS U19 HL129902NIAID NIH HHS P30 AI027757NIAID NIH HHS U19 AI096111NIAID NIH HHS UM1 AI126623NIH HHS P51 OD010425
6 · The paper itself

Abstract

The conditioning regimen used as part of the Berlin patient's hematopoietic cell transplant likely contributed to his eradication of HIV infection. We studied the impact of conditioning in simian-human immunodeficiency virus-infected (SHIV-infected) macaques suppressed by combination antiretroviral therapy (cART). The conditioning regimen resulted in a dramatic, but incomplete depletion of CD4

Indexed as

Whole-Body IrradiationAnimalsAnti-Retroviral AgentsCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesHematopoietic Stem Cell TransplantationHIV-1HIV InfectionsHomeostasisLentivirus InfectionsMacaca nemestrinaSimian Acquired Immunodeficiency SyndromeSimian Immunodeficiency VirusTransplantation, AutologousTransplantation ConditioningViral LoadAnti-Retroviral Agents

Identifiers

PMID28239658
PMCPMC5322807
OpenAlexW2589245473

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.